![]() |
|
|
Center for Research in Nutrition and Health, Instituto Nacional de Salud Pública, Cuernavaca, México and * Childrens Nutrition Research Center and Section of Neonatology, Department of Pediatrics, Baylor College of Medicine and Texas Childrens Hospital, Houston, TX
3To whom correspondence should be addressed. E-mail: svillalp{at}insp.mx.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: iron absorption stable isotopes fortification
Anemia and iron deficiency are still public health problems globally. The most vulnerable group is young children whose prenatal iron stores are sufficient to maintain an adequate iron status for only the first 46 mo of life (1,2). After that period, the increased iron requirements for growth and a limited supply from breast milk (3) frequently result in iron deficiency with or without anemia, especially in many developing countries (4,5). Therefore, during this critical period, the primary sources of dietary iron are complementary foods with highly bioavailable iron or iron-fortified milk formulas (6). The high prevalence of iron deficiency anemia is of great relevance for public health in developing countries because of its negative effects on the survival (7) and future health of young children (811).
In 1999, 27% of Mexican children <5 y old were anemic. Iron deficiency (the percentage of transferrin saturation <16%) was present in 64% of anemic children and 48% of nonanemic children. Children from 12 to 23 mo of age were the most commonly affected, with a prevalence of anemia of 50% and of iron deficiency of 67% (12,13). Therefore, efforts are underway to improve the iron status of the population of this age. One of the interventions aimed at improving the iron status of small children that has been implemented by the Mexican Government is an integrated educational, health, and nutritional program. This program, PROGRESA (currently named "Oportunidades") serves >4 million impoverished families, at an annual cost of
$2 billion (14). As a part of the nutrition intervention, the program provides a milk-based complementary food fortified with iron, zinc, folic acid, and vitamins A, C, E, and B-12 to children between 6 mo and 2 y of age (Table 1). An impact evaluation carried out in 1820 children 12 to 30 mo of age after 1 y of intervention, showed a positive effect on linear growth of 1 cm gain, and a 30% increase in the mean retinol and folic acid concentrations in intervened relative to nonintervened children (control group) (15). The prevalence of anemia in intervened children dropped from 46 to 40%, but there was no significant effect on their iron status. It is likely that the reduction in the prevalence of anemia was caused principally by the improvement in folate and vitamin A status.
|
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Children were randomly assigned, stratified by gender, to consume the milk-based weaning food fortified with ferrous sulfate, ferrous fumarate, or reduced iron with Na2EDTA. To adapt to the supplement, children received a daily serving of the weaning food for 15 d before the stable isotope study. Due to the high prevalence of infection by helminthes, all children received 400 mg albendazole as a single oral dose on d 5 of this period.
Subjects arrived at the community health center in the morning of d 16 of the study. Parents had been asked to not give them any breakfast before coming to the center. They received 1 serving of one of 3 complementary foods fortified with ferrous sulfate, ferrous fumarate, or reduced iron with Na2EDTA, labeled with 1.5 mg of 58Fe in the chemical form matched to the fortifier type they had been receiving at home previously. The total iron content of the test meal, including the tracer, was 1.79 mmol (10 mg). All of the children consumed the entire labeled meal as served. The test meals were administered in plastic, trace element-free containers by one member of the research team. The following day, again after not receiving a breakfast, children were administered an oral reference dose of 0.716 mmol (4.0 mg) of 57FeSO4 with 2.83 mmol (50 mg) of ascorbic acid that had been diluted in 70 mL of nonvitamin-enriched grape juice. Only water was allowed for the 2 h after isotope administration. Fourteen days later (d 31 of the study), a 4-mL venous blood sample was obtained to determine the ferritin and C-reactive protein (CRP) concentrations in plasma and the isotopic enrichment of the RBC. Weight and height were measured according to standard methods (23).
Characteristics of the complementary food.
The complementary food was prepared for this study by the same manufacturer that supplies the governmental program PROGRESA (Liconsa), following the formulation shown in Table 1. In short, the main ingredients included powdered milk (54.9%), maltodextrins (37.2%), sugar (5.7%), flavoring substances, and iron, zinc, retinol, riboflavin, vitamin B-12,
-tocopherol, vitamin C, and folate. In the manufacturing plant, the ingredients were mixed in a mechanical type "V" mixer until homogenized in the following sequence: milk powder, maltodextrins (from hydrolyzed cornstarch), flavoring substances, and vitamins and minerals premixed with an aliquot of hydrolyzed cornstarch, and finally sugar. Complementary foods were prepared by end users for consumption by adding
25 mL of water (2 tablespoons) to 44 g of powder, giving it a purée consistency. Each serving provided 1.79 mmol (10 mg) of iron and 2.11 mmol (37.4 mg) of vitamin C.
Labeling of the test meals. 57Fe and 58Fe (>90% enriched (Trace Sciences International) were purchased and used to prepare the iron tracers. 58Fe labeled ferrous fumarate was synthesized by the manufacturer by a standard method (24) and provided as a dry powder. Powdered, reduced 58Fe was provided by the manufacturer at a particle size of 325 mesh (same particle size of the reduced iron used as fortificant for the complementary food). No further analyses were performed to assess compatibility with the commercial compound. To make ferrous sulfate, reduced iron isotopes, in ingots, were dissolved with H2SO4 to obtain 57Fe SO4 and 58Fe SO4 solutions (25). The isotopic enrichment of solutions was verified by magnetic sector thermal ionization MS (MAT 261, Finnigan Thermoquest). Glass vials were filled with isotope solutions and stored at 4°C.
Labeling of the milk-based weaning food.
The reduced 58Fe powder was mixed with Na2EDTA in a 1:1 molar ratio, added to a small portion of weaning food powder, and thoroughly mixed. The isotope container was rinsed several times to ensure the transference of the entire isotope dose. Then the weaning food powder was reconstituted with water, mixed again, and divided into 18 equal doses using a precision scale. 58Fe SO4 and fumarate already in aqueous solution were extracted from the vial as individual doses with plastic syringes and added to small portions of previously reconstituted weaning food of equal weight. The unlabeled weaning food (
398 g/iron compound) was weighed on a calibrated scale with a precision of ±0.1 g and divided into 18 equal test meals (
22.1 g/test meal).
Laboratory determinations. Samples of the meals were digested with nitric acid and their iron content determined by atomic absorption spectrometry (Analyst 300, Perkin Elmer). Hemoglobin concentrations were determined from capillary blood samples using a portable photometer (HemoCue). Blood samples were drawn into trace metal-free, evacuated tubes with EDTA (Vacutainer, Beckton Dickinson). Plasma was separated after centrifugation at 1400 x g for 15 min and preserved in liquid nitrogen until ferritin and CRP were determined. The quantitative measurement of ferritin was determined by sandwich immunoassay (ELISA, Opus Behring Laboratories) using commercial kits (Dade Behring). CRP in serum was determined by an immunonephelometry system using a commercial kit (Dade-Behring). The cutoff point used to detect abnormal values was >3 g/L, as suggested by the manufacturer (26).
Determinations of isotope ratios. RBC were washed with saline and then frozen until analysis. Iron absorption was calculated from the enrichment in the RBC of the iron isotopes as described previously (27). Briefly, 0.30.5 mL RBC were digested with 10 mL of 15 mol/L nitric acid on a hot plate overnight. The digest was allowed to cool and redissolved in 0.6 mL of 6 mol/L ultrapure hydrochloric acid before being separated by anion exchange. A column (8-cm long x 0.4-cm diameter) was loaded with anion exchange resin (AG 1-X8; Bio-Rad Laboratories) and prewashed with 4 and 1 mL of 6 mol/L ultrapure hydrochloric acid. The sample was then loaded onto the column, followed by 6 mL of 6 mol/L ultrapure hydrochloric acid and 0.5 mL of 0.5 mol/L ultrapure hydrochloric acid. The sample was eluted from the column with 1 mL of 0.5 mol/L ultrapure hydrochloric acid into a teflon vial, dried on a hot plate, and dissolved in 40 µL of 3% ultrapure hydrochloric acid. Then 10 µL of the sample was loaded onto rhenium filaments with 2 µL of 0.7 mol/L phosphoric acid and 6 µL silica gel; the iron isotope ratio was measured with a thermal ionization magnetic sector MS (MAT 261; Finnigan). Replicate blocks of 10 scans each were performed until the required degree of precision (<0.2%) was achieved. The results were expressed as the ratio of 58Fe to iron-56. The ratio of the 2 nonadministered isotopes (iron-56 and iron-54) was used to correct for temperature-specific differences in fractionation (27). Trace element-free reagents and disposables were used throughout.
Calculations.
Incorporation into erythrocytes of the administered 57Fe and 58Fe (Feinc) was calculated from enriched (enr) and baseline (base) isotope ratios as follows:
![]() |
where NA is the natural abundance of the isotope. Feinc is the total circulating iron estimated assuming a total blood volume of 65 mL/kg, the measured Hb concentration, and the iron concentration in Hb (3.47 mg/g). The same calculation was done for 58Fe. Correction of cross-contamination of stable isotopes was made using tracer/tracee methodology. Results are expressed as the percentage of administered dose of each isotope incorporated into erythrocytes.
Sample size calculations were based on a 5% variability of iron absorption and expected differences among fortificants of 2.8%, as observed in previous studies (28,29). Considering a power of 80% and a 5% level of significance, a total sample size of 54 children (18 per group) including attrition was determined.
Statistical analysis. Iron absorption for each iron compound was measured from the incorporation of 58Fe into RBC at d 14 as described previously; a figure of 90% of absorbed iron incorporated into RBC 14 d after dosing is typically applied at this age (30).
The absolute differential iron absorption among the iron sources tested was assessed by ANOVA and analysis of covariance, corrected by ferritin and the absorption of the reference dose as covariates. Then, to account for iron-deficient populations, absolute iron absorption was adjusted to 40% of the absorption of the reference dose. The resulting equation. separately regressing iron absorption from each iron compound tested on the iron absorption from the reference dose, was used for this 40% adjustment. Students t test and a post-hoc Tukey-Kramer test were used for comparisons of iron absorption values among iron source groups. Differences were considered significant at P < 0.05. For comparisons among discrete variables, we used
2 tests. Correlations among iron absorption from the tested meal, the reference dose, and serum ferritin concentrations were assessed by Pearsons correlation. Serum ferritin and iron absorption values were not normally distributed; thus, they were normalized by log transformation before statistical analyses. Data are presented as geometric means, SD, and proportions. Data analyses were performed with Stata statistical software (V. 7.0).
Anemia was defined as a hemoglobin concentration <110 g/L (corrected by altitude) and iron deficiency as a serum ferritin <26.9 pmol/L (12 µg/L).
| RESULTS |
|---|
|
|
|---|
|
|
| DISCUSSION |
|---|
|
|
|---|
Absolute iron absorption from ferrous sulfate was the greatest among the 3 iron sources tested (7.9%). It was similar to that observed in Jamaican children for ferrous sulfate added to chocolate-flavored milk (31), but slightly lower than the absorption observed in Chilean children when ferrous sulfate was added to powdered milk (10%) (17). Iron absorbed from ferrous fumarate was much lower (2.4%) than the percentage absorbed from iron sulfate. It was comparable, however, to the absorption of iron from ferrous fumarate in a chocolate drink (2.8%), in adults (32).
According to figures of iron absorption presented here, a recommended daily portion of the weaning food fortified with ferrous sulfate would allow a mean of absorbed iron per day equal to 0.141 mmol/d (0.79 mg/d) [range = 0.0460.758 mmol/d (0.264.24 mg/d)]. Fortification with ferrous fumarate would provide 0.042 mmol/d (0.24 mg/d) [range = 0.0100.195 mmol/d (0.061.09 mg/d)]. Finally, fortification with reduced iron + Na2EDTA would provide 0.025 mmol/d (0.14 mg/d) [range = 0.0010.096 mmol/d (0.010.54 mg/d)]. The daily requirement of absorbed iron proposed for children 0.55.5 y of age ranges from 0.096 to 0.125 mmol (0.540.7 mg) (33). On this basis, the mean absorbed iron from ferrous sulfate and ferrous fumarate when added to the fortified weaning food could meet 113146% of the daily requirement for children 13 y of age. Absorption from reduced iron + Na2EDTA (2026% of the requirements) may be inadequate to produce a measurable effect on the iron status of children receiving the fortified weaning food tested in this study. The study population had a high incidence of iron deficiency; thus, they would require more than the "maintenance" level of iron to correct this. Indeed, the actual amount of iron absorbed by infants in the present study from one serving of PROGESSA fortified with reduced iron varied between 0.001 and 0.89 mmol/d (0.01 and 0.5 mg/d).
There was a negative correlation between the log 58Fe absorption and log ferritin concentration from ferrous sulfate; in contrast this relation was not significant for ferrous fumarate and reduced iron + Na2EDTA. Nevertheless, the log 57Fe absorption correlated with log ferritin only in the sulfate group, but not in the other 2 groups. This differential lack of correlation might have several causes. First, in this population with a high risk of iron deficiency, ferritin concentrations tend to be low, and variability is therefore very limited. Thus, in the majority of cases, iron absorption is as high as possible, and there are an insufficient number of subjects with high iron status to represent the reduced rate of iron absorption seen at this end of the spectrum. Second, the absorption of the reference dose and plasma ferritin may not correct individual variations in iron absorption as was suggested by Davidsson et al. (34). Finally, ferritin might not be the best indicator of iron status in children in this age group. Margolis et al. (35) found that the best predictor for response to iron supplementation in children was hemoglobin compared with s-ferritin, transferrin saturation, and erythrocytes protoporphyrin. Hershko et al. (36) found that ferritin was not the most reliable index of iron status in Israeli children. In that study, the iron absorption from ferrous sulfate, in both the test meal and the reference dose, was the only one to have a clearly significant correlation with iron status. Further, iron absorption from 58Fe and 57Fe ferrous sulfate correlated well between them (R2 = 0.32, ß = 0.62, P = 0.01), but similar correlations between 58Fe and 57Fe from ferrous fumarate or reduced iron were not significant (P = 0.2). On the basis of these findings, we speculate that the full water solubility of ferrous sulfate allows iron absorption to maintain a clear association with the iron status of the subjects tested. On the contrary, the lower water solubility of ferrous fumarate and reduced iron require an acidic milieu to be absorbed. Reduced acid output in Helicobacter pylori infections is an important limiting factor of iron absorption, especially for ferrous fumarate, altering it irregularly independently of iron status (37). The prevalence of this infection is as high as 50% in Mexican children (38) as in many other developing countries.
In an attempt to ensure that the tracer compounds were absorbed to the same extent as the specific iron fortificants that they were meant to label, the tracers were provided in the same chemical form as the respective fortificants. However, the physical forms of the tracers varied slightly, in that the ferrous sulfate was added to the prepared meals as an aqueous solution, whereas the ferrous fumarate and reduced iron + Na2EDTA were added as dry powders. Nevertheless, this difference in the physical forms of the tracers was unlikely to have confounded the results because ferrous sulfate is readily water soluble over a wide pH range. Thus, even if the ferrous sulfate had been added as a powder, it would have entered into solution very rapidly. By contrast, ferrous fumarate and reduced iron + Na2EDTA are soluble only at pH < 2 (39). Therefore, it would not have been appropriate to add these tracers to the test meals as low-pH solutions, because it could have altered the meals natural condition. For this reason, the later tracers were added as dry powders, conserving the meals and tracers in their natural condition.
This study tested a single food; if its results are considered in making programmatic decisions, consideration must be given to the balance between iron absorption enhancers and inhibitors in the whole meal consumed with the supplement, and the prevalence of parasitic infections of the target population, which are known causes affecting iron status. The government authorities of Mexico decided to change the iron source to sulfate for use in the weaning food. Such a decision was based primarily on the data presented here.
We presented an example of the need to conduct bioavailability studies for planning effective interventions with iron-fortified foods. To be effective, food iron-fortification strategies must not only ensure the content of adequate amounts of iron in the food vehicle, a successful delivery system, its acceptance, and its consumption by the target population, but they also must guarantee that the form of iron added to the particular food vehicle of choice is absorbed in adequate amounts. If the latter condition is not in place, the intervention will be ineffective, regardless of how satisfactory the other conditions are.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supported in part by the International Atomic Energy Agency (grant RLA 007). ![]()
Manuscript received 2 July 2004. Initial review completed 9 August 2004. Revision accepted 1 October 2004.
| LITERATURE CITED |
|---|
|
|
|---|
1. ACC/SCN (2000) Fourth Report on the World Nutrition Situation 2000 ACC/SCN in collaboration with IFPRI Geneva, Switzerland.
2. Domellöf, M., Cohen, R. J., Dewey, K. G., Hernell, O., Landa Rivera, L. & Lönnerdal, B. (2001) Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age. J. Pediatr. 138:679-687.[Medline]
3. Abrams, S. A., Wen, J. & Stuff, J. E. (1996) Absorption of calcium, zinc, and iron from breast milk by five- to seven-month-old infants. Pediatr. Res. 41:384-390.
4. Oski, F. A. (1993) Iron deficiency in infancy and childhood. N. Engl. J. Med. 329:190-193.
5. Lönnerdal, B. & Hernell, O. (1994) Iron, zinc, copper and selenium status of breast-fed infants and infants fed trace element fortified milk-based infant formula. Acta Paediatr. 83:367-373.[Medline]
6. Person, L. A., Lundström, M., Lönnerdal, B. & Hernell, O. (1998) Are weaning foods causing impaired iron and zinc status in 1-year-old Swedish infants? A cohort study. Acta Paediatr. 87:618-622.[Medline]
7. Brabin, B. J., Premji, Z. & Verhoeff, F. (2001) An analysis of anemia and child mortality. J. Nutr. 131:636S-648S.
8. Angeles, I. T., Schultink, W. J., Matulessi, P., Gross, R. & Sastroamidjojo, S. (1993) Decreased rate of stunting among anemic Indonesian preschool children through iron supplementation. Am. J. Clin. Nutr. 58:339-342.
9. Pollit, E. (2001) The developmental and probabilistic nature of the functional consequences of iron-deficiency anemia in children. J. Nutr. 131:669S-675S.
10. Oppenheimer, S. J. (2001) Iron and its relation to immunity and infectious disease. J. Nutr. 131:616S-635S.
11. Haas, J. D. & Brownlie, T. (2001) Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J. Nutr. 131:676S-690S.
12. Villalpando, S., García-Guerra, A., Ramírez, C. I., Mejía, F., Matute, G., Shamah, T. & Rivera, J. (2003) Iron, zinc, and iodide status in Mexican children under 12 years and women 1249 years of age. A probabilistic national survey. Salud Pub. Mex. 45:520-529.
13. Villalpando, S., Shamah, T., Ramírez, C. I., Mejía, F. & Rivera, J. A. (2003) Prevalence of anemia in children 6 months to 12 years of age. Results of a nationwide probabilistic survey in Mexico. Salud Pub. Mex. 45:490-498.
14. Sistema de Cuentas Nacionales y Estatales de Salud (2001) Secretaría de Salud. México 2001 Internet: http://www.salud.gob.mx [accessed 14 July 2003].
15. Rivera, J. L., Sotrès, D., Habitch, J. P., Shamah, T. & Villalpando, S. (2004) Impact of the Mexican program for education, health and nutrition (PROGRESA) on rates of growth and anemia in infants and young children. J. Am. Med. Assoc. 291:2563-2570.
16. Turner, L. (2002) Monterrey Workshop summary: evaluating the usefulness of elemental iron powders. Nutr. Rev. 60:S16-S17.[Medline]
17. Stekel, A., Olivares, M., Pizarro, F., Chadud, P., Cayazzo, M., Lopez, I. & Amar, M. (1986) Prevention of iron deficiency in infants by fortified milk. Field study of a low-fat milk. Arch. Latinoam. Nutr. 36:654-661.[Medline]
18. Zlotkin, S., Arthur, P., Antwi, K. Y. & Yeung, G. (2001) Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods. Am. J. Clin. Nutr. 71:791-795.
19. MacPhail, A. P., Patel, R. C., Bothwell, T. H. & Lamparelli, R. D. (1994) EDTA and the absorption of iron from food. Am. J. Clin. Nutr. 59:644-648.
20. Fairweather-Tait, S. J., Wortley, G. M., Teuchder, B. & Danty, J. (2001) Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid. Int. J. Vitam. Nutr. Res. 71:117-122.[Medline]
21. Davidsson, L., Dimitriou, T., Boy, E., Walczyk, T. & Hurrell, R. F. (2002) Iron bioavailability from iron-fortified Guatemalan meals based on corn tortillas and black bean paste. Am. J. Clin. Nutr. 75:535-539.
22. Davidsson, L., Walczyk, T., Zavaleta, N. & Hurrell, R. (2001) Improving iron absorption from a Peruvian school breakfast meal by adding ascorbic acid or Na2EDTA. Am. J. Clin. Nutr. 73:283-287.
23. Lohman, T. G., Roche, A. F. & Martorell, R. (1988) Anthropometric Standardization Reference Manual 1988 Human Kinetics Publishers Champaign, IL.
24. Prabhakaran, P. (1969) Synthesis of ferrous fumarate. Ind. J. Chem. 7:266-267.
25. Kastenmayer, P., Davidsson, L., Galan, P., Cherouvrier, F., Hercberg, S. & Hurrell, R. (1994) A double isotope technique for measuring iron absorption in infants. Br. J. Nutr. 71:411-424.[Medline]
26. Whicher, J. T., Ritchie, R. F., Johnson, A. M., Baudner, S., Bienvenu, J., Blirup-Jensen, S., Carlstrom, A., Dati, F., Ward, A. M. & Svendsen, P. J. (1994) New international reference preparation for proteins in human serum (RPPHS). Clin. Chem. 40:934-938.
27. Abrams, S. A., Wen, J., OBrien, K. O., Stuff, J. E. & Liang, L. K. (1994) Application of magnetic sector thermal ionization mass spectrometry to studies of erythrocyte iron incorporation in small children. Biol. Mass Spectrom. 23:771-775.[Medline]
28. Ames, S. K., Gorham, B. M. & Abrams, S. (1999) Effects of high compared with low calcium intake on calcium absorption and incorporation of iron by red blood cells in small children. Am. J. Clin. Nutr. 70:44-85.
29. Davidsson, L., Kadtenmayer, P., Szajewska, H., Hurrell, R. & Barclay, D. (2000) Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. Am. J. Clin. Nutr. 71:1597-1602.
30. Abrams, S. A. (1999) Using stable isotopes to assess mineral absorption and utilization by children. Am. J. Clin. Nutr. 70:955-764.
31. Davidsson, L., Walczyc, T., Morris, A. & Hurrell, R. F. (1998) Influence of ascorbic acid on iron absorption from an iron-fortified, chocolate-flavored milk drink in Jamaican children. Am. J. Clin. Nutr. 67:873-877.[Abstract]
32. Hurrel, R. F. (1991) Ferrous fumarate fortification of a chocolate drink powder. Br. J. Nutr. 65:271-283.[Medline]
33. Food and Nutrition Board (2001) Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2001 Institute of Medicine, National Academy Press Washington, DC.
34. Davidsson, L., Ziegler, E. E., Kastenmayer, P. & Hurrell, R. F. (2000) Erythrocyte incorporation of iron by infants: iron bioavailability from a low-iron infant formula and an evaluation of the usefulness of correcting erythrocyte incorporation values, using a reference dose or plasma ferritin concentrations. Br. J. Nutr. 84:847-853.[Medline]
35. Margolis, H. S., Huntley, H. H., Bender, T. R. & Dallman, P. R. (1981) Iron deficiency in children: the relationship between pretreatment laboratory tests and subsequent hemoglobin response to iron therapy. Am. J. Clin. Nutr. 34:2158-2168.
36. Hershko, C., Baror, D., Gaziel, Y., Naparstek, E., Konijn, A. M., Grossowicz, N., Kaufman, N. & Izak, G. (1981) Diagnosis of iron deficiency anemia in a rural population of children. Relative usefulness of serum ferritin, red-cell protoporphyrin, red-cell indexes and transferring saturation determinations. Am. J. Clin. Nutr. 34:1600-1610.
37. Sarker, S. A., Davidsson, L., Mahmud, H., Walczyk, H., Hurrel, R. F., Gyr, N. & Fuchs, G. J. (2004) Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children. Am. J. Clin. Nutr. 80:149-153.
38. Torres, J., Leal-Herrera, Y., Perez-Perez, G., Gomez, A., Camorlinga-Ponce, M., Cedillo-Rivera, R., Tapia-Conyer, R. & Muñoz, O. (1998) A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J. Infect. Dis. 178:1089-1094.[Medline]
39. Hurrel, R. (2002) How to ensure adequate iron absorption from iron fortified food. Nutr. Rev. 60:S7-S15.
This article has been cited by other articles:
![]() |
S. Adu-Afarwuah, A. Lartey, K. H Brown, S. Zlotkin, A. Briend, and K. G Dewey Home fortification of complementary foods with micronutrient supplements is well accepted and has positive effects on infant iron status in Ghana Am. J. Clinical Nutrition, April 1, 2008; 87(4): 929 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wijaya-Erhardt, J. G Erhardt, J. Untoro, E. Karyadi, L. Wibowo, and R. Gross Effect of daily or weekly multiple-micronutrient and iron foodlike tablets on body iron stores of Indonesian infants aged 6 12 mo: a double-blind, randomized, placebo-controlled trial Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1680 - 1686. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||